Physician profile
Alan M Keating
NPI 1063487015
$503.76
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.25 · 2022: $165 · 2023: $173 · 2024: $73.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $143.14 | 2022-2023 | Krystexxa |
| Amgen INC. | $120.17 | 2022 | |
| Smith+Nephew, INC. | $48.26 | 2023-2024 | Pico 14, Pico 7, Renasys Go V2 Home |
| Collegium Pharmaceutical, INC. | $41.87 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $41.63 | 2024 | Airsupra |
| Vericel Corporation | $33.56 | 2022-2023 | Maci |
| Boston Scientific Corporation | $25.75 | 2023 | Wavewriter Alpha Prime 16 |
| Biogen, INC. | $20.26 | 2021 | |
| Pacira Therapeutics, INC. | $14.65 | 2021 | |
| Abbott Laboratories | $14.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.